Connect

Capabilities

End-to-end capabilities to transform your value chain and create lasting impact
Discover Capabilities

Explore

Technologies

Proprietary software products that enable smarter decisions across the value chain
Discover Technologies
  • Helion

Axon™ Value chain Analytics & decision intelligence

Discover Axon

Solutions

AI & Agents

Binocs™ Scheduling and Capacity Planning For QC and Advanced Therapies

Discover Binocs

Solutions

Use cases

AI & Agents

Digital & AI

Digital, data and AI solutions to modernize, transform and unlock intelligent outcomes
Discover Digital & AI

Cross-capabilities

Let's Talk
Binocs CGT Panel Discussion White paper Industrializing the next generation of cell and gene therapies mockup
‹ Back
Insights / Whitepapers

Industrializing the next generation of cell and gene therapies

16 Sep 2022

As more advanced therapies hit the market, the challenges of scaling CGT operations to meet demand grows. Our experts offer some handy tips!

Scaling CGT operations is critical to meet the growing demand for treatment.

20% of cancer patients who are eligible for CAR-T therapies pass away while waiting for a manufacturing slot.

Although companies are increasing their capacity, they are simultaneously expanding the volume and range of therapies they offer at a faster rate.

Scaling CGT manufacturing capacity to meet increasing demand significantly amplifies operational complexity.

With more assets to manage, greater variation in protocols and an increased need for clear and timely communication between stakeholders, CGT teams are confronted with a growing list of logistical hurdles. How can the industry enhance operations to ensure no eligible patients are left untreated?

To find out, we assembled an expert panel of CGT developers, a CDMO and a treatment center to discuss their most urgent challenges and how they are working to solve them.

In this whitepaper, you will learn from our panel of experts how they are:

  • Managing complex operations and communicating information between developers, CDMOs and healthcare facilities
  • Addressing key challenges associated with scheduling and rescheduling batch manufacturing and patient care
  • Managing exceptions in slot allocation to minimize the impact on planned activities
  • Managing capacity across manufacturing networks and maximizing opportunities to treat patients
  • Simplifying IT processes to optimize CGT service delivery

Want to learn more? Download the whitepaper now!

Other Whitepapers

Bluecrux Merck white paper 1 Whitepaper

Digital Transformation in Pharmaceutical Capacity Management

Read more
1bac6e36 e378 4323 b132 b001b7ada857 Whitepaper

Dissolving Silos with Synergy: a collaborative approach to integrating supply chain and QC

Read more
5 lean lab principles white paper mockup Whitepaper

The 5 principles of the lean lab

Read more